The Company and its subsidiaries are principally engaged in (1) manufacture and sales of Chinese patent medicine; (2) wholesale, retail, import and export of western and Chinese pharmaceutical product >>>>>>
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019
Date Documents
29-05-2008 18:13 ANNOUNCEMENT OF THE RESOLUTIONS PASSED AT THE 2007 ANNUAL GENERAL MEETING
29-04-2008 16:31 2008 FIRST QUARTERLY REPORT
17-04-2008 17:38 Announcement on the Listing of Tradable Shares with Selling Restrictions
15-04-2008 16:31 Date of Board Meeting
11-04-2008 23:19 NOTICE OF THE 2007 ANNUAL GENERAL MEETING
28-03-2008 23:42 ANNOUNCEMENT OF RESOLUTIONS PASSED AT THE FIFTH MEETING OF THE FOURTH SESSION OF THE BOARD
28-03-2008 23:41 Summary of 2007 Annual Report
28-03-2008 19:35 ANNOUNCEMENT OF RESOLUTIONS PASSED AT THE FOURTH MEETING OF THE FOURTH SESSION OF THE SUPERVISORY COMMITTEE
28-03-2008 18:27 CONTINUING CONNECTED TRANSACTIONS
13-03-2008 18:02 Notice of Board Meeting
29-02-2008 18:20 ANNOUNCEMENT
28-01-2008 18:01 COMPLETION OF THE MAJOR TRANSACTION